Sweden becomes first country to meet global HIV targets

Plus, news about In­ozyme and Sen­so­ri­on: LIB Ther­a­peu­tics touts pos­i­tive Phase 3 cho­les­terol re­sults: The com­pa­ny’s third-gen­er­a­tion PC­SK9 in­hibitor, lero­dal­cibep, achieved a 56% LDL-C re­duc­tion

What has caused this young woman in her 20s to develop heart palpitations and shortness of breath? That’s what Xuhong Geng, MD, of Fourth Hospital

HOUSTON — Pediatric treatment protocols outperformed standard therapy for adolescents and young adults (AYAs) with Philadelphia chromosome-negative acute lymphocytic leukemia (ALL), a retrospective cohort study